A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device

NAEnrolling by invitationINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

January 31, 2026

Conditions
Cataract Surgery
Interventions
DEVICE

miCOR System

The miCOR system is a lens fragmentation device used to break up the cataract prior to IOL implantation during cataract surgery.

DEVICE

Phaco Subject Cohort

Phaco Subject Cohort

Trial Locations (6)

17033

Penn State Health Eye Center, Hershey

23502

Virginia Eye Consultants, Norfolk

33409

Mittleman Eye, West Palm Beach

33904

Argus Research at Cape Coral Eye Center, Cape Coral

52233

Wolfe Eye Clinic, Hiawatha

53405

The eye Centers of Racine and Kenosh, Racine

Sponsors
All Listed Sponsors
lead

Carl Zeiss Meditec, Inc.

INDUSTRY

NCT05729477 - A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device | Biotech Hunter | Biotech Hunter